News & updates

From internship project to the European market: LUMC device allows surgeons to detect tumors more precisely

Created on:


February 25, 2021

The DROP-IN gamma probe technology developed at the LUMC has received CE certification. This means that hospitals throughout Europe can use the device. The probe improves the detection of tumors during operation procedures with a surgical robot. The technology is currently being commercialized by Crystal Photonics. What started off as an internship project has turned into a product that has reached the market. What did this process look like?

Matthias van Oosterom, a postdoc in the Department of Radiology, began his internship at the LUMC in 2014 with the Interventional Molecular Imaging group. His project entailed developing a device that would enable better detection of prostate tumors during image-guided surgery. “During image-guided operations, such as radio-guided surgery, patients are first administered a tracer that goes into the tumor. With a probe that detects the tracer, the surgeon know when the tracer is near the tumor, allowing the precise removal of tumor tissue”, explains Van Oosterom.


More news & updates

AE-TBC wins EDCTP’s Outstanding Research Team 2020 prize!

November 2, 2021

The African-European Tuberculosis Consortium (AE-TBC) is an international multisite group of African and European researchers who investigate the use of host biosignatures for the diagnosis of active TB disease. For over ten years, the LUMC groups of Infectious Diseases and Cell & Chemical Biology from Prof Annemieke Geluk and Dr Paul Corstjens respectively, have been partners of the EDCTP consortia for tuberculosis (among which AE-TBC). The AE-TBC recently won the prize for ‘Outstanding Research Team 2020, awarded by the EDCTP.

Background Image Of A Scientist Recording Test Results In A Lab

Janssen COVID-19 vaccine approved for use in EU on March 11

March 11, 2021

The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.

VODAN-Africa Health System is being deployed across 88 health facilities in 8 African countries

April 21, 2022

“This is an achievement in alignment with the mission of VODAN-Africa to generate continuous, real-time, high velocity clinical observational patient data from resource-limited communities that have not been well represented in digital health data. The key feature is that the data produced remains in the health facility only. It will not leave the health facility. Since the data is machine-actionable the input of the data only happens once; in the deployable architecture, the data is used for four parallel use cases” (VODAN to Africa, 2022).

Stay up to date with news, inspirations and events.

© LUMC Global. All rights reserved. Website door philogirl

Contact

Social